|[July 07, 2014]
Research and Markets: Hemoglobin A1c Testing Markets Report 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/lckbnn/hemoglobin_a1c)
has announced the addition of the "Hemoglobin
A1c Testing Markets" report to their offering.
Hemoglobin A1c (HbA1c) testing is the most recent major technology to
have entered the diabetes testing market. As the global prevalence of
diabetes mellitus continues to increase rapidly, with more than 366
million diabetics worldwide, hemoglobin A1c testing is now an essential
assay in the diabetes testing repertoire. Its clinical utility and
improvements in its accuracy and implementation of standardized
protocols have translated into continued market growth.
The study reviews ll of the generally accepted clinical analytical
methods that are currently in use today for measuring HbA1c levels.
Moreover, it examines clinical measurement devices and reagents as
utilized in hospitals, clinics, doctor's offices and at-home care
locations. The report also analyzes almost all of the companies known to
be marketing, manufacturing or developing hemoglobin A1c testing.
Detailed tables and charts with sales forecasts and marketshare data are
Key Topics Covered:
3. Market Analysis: Size, Growth, Share and Competitors
4. Overview of HbA1c Testing
5. HbA1c Testing Devices on the Market
6. Business Trends in HbA1c Testing
7. Regulatory Environment and Insurance Reimbursements
8. Company Profiles
A. Menarini Diagnostics
ARKRAY USA, Inc.
Axis (News - Alert)-Shield Plc
Bayer Healthcare Diagnostics
Beckman Coulter, Inc
Bio-Rad Laboratories, Inc.
Infopia Co., Ltd.
Ortho Clinical Diagnostics (part of Johnson & Johnson)
Siemens AG (News - Alert)
Tosoh Bioscience, Inc.
Trinity Biotech Plc
For more information visit http://www.researchandmarkets.com/research/lckbnn/hemoglobin_a1c
[ Back To TMCnet.com's Homepage ]